Accreditation Information

In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing (ANCC)

This activity is designated for 1.0 contact hour.

Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

Upon completion of a CNE request form, statements of credit for nurses will be issued within 30 business days.

ONCC/ILNA Certification Information

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points. OCN®, AOCNP®, AOCNS®, CBCN®, CPHON®, and BMTCN® nurses may apply 1.0 point in Diagnosis and Staging, Professional Practice, Scientific Basis for Practice, and Treatment categories.

Disclaimer: ONCC review is only for designating content to be used for recertification points and is not for CNE accreditation. CNE programs must be formally approved for contact hours by an acceptable accreditor/approver of nursing CE to be used for recertification by ONCC. If the CNE provider fails to obtain formal approval to award contact hours by an acceptable accrediting/approval body, no information related to ONCC recertification may be used in relation to the program.

Objectives

At the conclusion of this activity participants will be able to:

1. Analyze the rapidly changing paradigm in clinical approaches to various B-cell malignancies and discuss new and emerging therapeutic options.
2. Examine key issues in therapy selection, including appropriate sequencing and combination of agents in a range of clinical scenarios based on individual patient factors, as well as disease and treatment status.
3. Identify strategies to successfully incorporate novel therapies for B-cell malignancies, including the growing range of targeted therapies, into clinical practice.

Target Audience

This activity is designed to meet the educational needs of oncology nurses and nurse practitioners attending local ONS Chapter Meetings across the U.S.

Faculty Disclosure

In accordance with the Food and Drug Administration, the speakers have disclosed that there is the potential for discussions concerning off-label uses of a commercial product/device during this educational activity.

Any person who may contribute to the content of this continuing education activity must disclose relevant relationships (and any known relationships of their spouse/partner) with commercial interests whose products or services are discussed in educational presentations. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Relevant relationships include receiving from a commercial interest research grants, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.

 Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Planner: 
Adrienne Matson, PharmD - has no relevant financial relationships to disclose in relation to the content of this activity.
 
Authors/Presenters:
Katherine L. Byar, MSN, ANP-BC, BMTCN—has no relevant financial relationships to disclose in relation to the content of this activity.

Amy L Goodrich, RN, MSN, CRNP-AC—has disclosed that she is a consultant for Gilead, Mylan, and Sandoz.

Barbara Rogers, CRNP, MN, AOCN, ANP-BC—has disclosed that she is a consultant for Cardinal Health, Genentech, and Merck. She is on the speakers' bureau for AbbVie, Genentech, and Seattle Genetics.

Reviewer:
Jeannie Patrick, PharmD, BCOP–has no relevant financial relationships to disclose in relation to the content of this activity.